Adenosine
Back to searchMolecule Structure
Scientific Name
Adenosine
Description of the Drug
Adenosine is a medication used in myocardial perfusion scintigraphy and to treat supraventricular tachycardia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00640
http://www.drugbank.ca/drugs/DB00640
Brand Name(s)
Adenocard, Adenocor, Adenoscan, Adenosine
Company Owner(s)
Fresenius Kabi Usa Llc, Mylan Laboratories Ltd, Hospira Inc, Gland Pharma Ltd, Astellas Pharma Us Inc, American Regent Inc, Eugia Pharma Specialities Ltd, Wockhardt Ltd, Mylan Asi Llc, Teva Pharmaceuticals Usa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adenosine receptor | PROTEIN FAMILY | AGONIST | CHEMBL2111329 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL731 | ||
| PharmGKB | PA448049 | ||
| Human Metabolome Database | HMDB0000050 | ||
| DrugBank | DB00640 | ||
| PubChem: Thomson Pharma | 14799162 | 14774851 | |
| PubChem | 60961 | ||
| Mcule | MCULE-7071766082 | MCULE-6268373280 | |
| NMRShiftDB | 60018497 | ||
| LINCS | LSM-28568 | ||
| Nikkaji | J4.501B | ||
| PDBe | ADN | ||
| BindingDB | 14487 | ||
| EPA CompTox Dashboard | DTXSID1022558 | ||
| DrugCentral | 90 | ||
| Metabolights | MTBLC16335 | ||
| Brenda | 122 | 99843 | |
| Rhea | 16335 | ||
| ChemicalBook | CB7304660 | ||
| Guide to Pharmacology | 2844 | ||
| rxnorm | ADENOSCAN | ADENOCARD | ADENOSINE |
| PubChem: Drugs of the Future | 81044335 | ||
| KEGG Ligand | C00212 | ||
| ChEBI | 16335 | ||
| ZINC | ZINC000002169830 |
